n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Peripheral Nerve Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsson, S; Cavaletti, G; Glimelius, B; Lustberg, M; Muro, K; Nagahama, F; Näsström, J; Persson, A; Pfeiffer, P | 1 |
| Teng, C; Vardy, JL | 1 |
| Grothey, A; Loprinzi, CL; Pachman, DR; Ta, LE | 1 |
| Alexandre, J; Batteux, F; Benoit, E; Borderie, D; Chéreau, C; Coriat, R; Coste, J; Goldwasser, F; Lemaréchal, H; Mir, O; Nicco, C; Quinquis, L; Tréluyer, JM; Weill, B | 1 |
| Batteux, F; Cerles, O; Nicco, C | 1 |
2 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M).
Topics: Colorectal Neoplasms; Humans; Oxaliplatin; Peripheral Nervous System Diseases | 2022 |
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.
Topics: Action Potentials; Administration, Intravenous; Aged; Animals; Antineoplastic Agents; Antioxidants; Colorectal Neoplasms; Edetic Acid; Female; Humans; Hypesthesia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Middle Aged; Motor Activity; Muscle Contraction; Muscle, Skeletal; Nociception; Organoplatinum Compounds; Oxaliplatin; Oxidative Stress; Peripheral Nervous System Diseases; Pyridoxal Phosphate; Sciatic Nerve; Survival Analysis | 2014 |
3 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Peripheral Nerve Diseases
| Article | Year |
|---|---|
"POLAR-izing" Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy.
Topics: Humans; Neuroprotection; Oxaliplatin; Peripheral Nervous System Diseases; Pyridoxal Phosphate | 2022 |
The search for treatments to reduce chemotherapy-induced peripheral neuropathy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Edetic Acid; Female; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyridoxal Phosphate | 2014 |
[Cancer, reactive oxygen species and chemotherapy-induced peripheral neuropathy].
Topics: Animals; Antineoplastic Agents; Edetic Acid; Humans; Neoplasms; Peripheral Nervous System Diseases; Pyridoxal Phosphate; Reactive Oxygen Species; Superoxide Dismutase | 2014 |